<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS CONTAINED IN THE COMPANY'S QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <MULTIPLIER> 1,000,000 <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-31-2000 <PERIOD-START> JAN-01-2000 <PERIOD-END> SEP-30-2000 <CASH> 160 <SECURITIES> 1,707 <RECEIVABLES> 325 <ALLOWANCES> 21 <INVENTORY> 294 <CURRENT-ASSETS> 2,622 <PP&E> 2,620 <DEPRECIATION> 905 <TOTAL-ASSETS> 4,898 <CURRENT-LIABILITIES> 723 <BONDS> 223 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 0 <OTHER-SE> 3,952 <TOTAL-LIABILITY-AND-EQUITY> 4,898 <SALES> 2,355 <TOTAL-REVENUES> 2,678 <CGS> 297 <TOTAL-COSTS> 297 <OTHER-EXPENSES> 595<F1> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 12 <INCOME-PRETAX> 1,354 <INCOME-TAX> 427 <INCOME-CONTINUING> 928 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 928 <EPS-BASIC> 0.90 <EPS-DILUTED> 0.86 <FN> <F1>ITEM CONSISTS OF RESEARCH AND DEVELOPMENT EXPENSES. </FN>